Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dexamethasone sodium phosphate + povidone-iodine + isopropyl alcohol + lidocaine hydrochloride
- Development stage
- Unknown
- Lead developer
- Asclemed USA
- Modality
- Small Molecules
- Administration
- Intravenous, Intramuscular, Topical
01
Overview
**Dexlido** is an unapproved prescription combination kit containing **dexamethasone sodium phosphate**, **lidocaine hydrochloride**, **povidone-iodine**, and **isopropyl alcohol**. The pharmacologically central therapeutic component is dexamethasone sodium phosphate, a water-soluble injectable corticosteroid that acts via the **glucocorticoid receptor** to produce rapid anti-inflammatory and immunomodulatory effects; lidocaine hydrochloride provides local anesthesia by blocking **voltage-gated sodium channels**, while povidone-iodine and isopropyl alcohol serve antiseptic and skin-disinfection roles within the kit. Public labeling describes the kit for broad corticosteroid-responsive conditions when dexamethasone injection is used intravenously or intramuscularly and includes the local anesthetic and antiseptic components as part of the packaged procedural kit. DailyMed and related drug-label sources identify the packager as **Asclemed USA** and explicitly state that the product is an **unapproved drug product** whose labeling has not been approved by the FDA.
- Brand names
- Dexlido
- Other names
- dexamethasone sodium phosphate + lidocaine hydrochloride + povidone-iodine + isopropyl alcoholDexlido kit
02
Targets
NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on dexamethasone sodium phosphate + povidone-iodine + isopropyl alcohol + lidocaine hydrochloride.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dexamethasone sodium phosphate + povidone-iodine + isopropyl alcohol + lidocaine hydrochloride.